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Impaired neurodevelopment by the 
low complexity domain of CPEB4 
reveals a convergent pathway  
with neurodegeneration
Jihae Shin1, Johnny S. Salameh2 & Joel D. Richter1
CPEB4 is an RNA binding protein expressed in neuronal tissues including brain and spinal cord. 
CPEB4 has two domains: one that is structured for RNA binding and one that is unstructured and low 
complexity that has no known function. Unstructured low complexity domains (LCDs) in proteins are 
often found in RNA-binding proteins and have been implicated in motor neuron degenerative diseases 
such as amyotrophic lateral sclerosis, indicating that these regions mediate normal RNA processing as 
well as pathological events. While CPEB4 null knockout mice are normal, animals expressing only the 
CPEB4 LCD are neonatal lethal with impaired mobility that display defects in neuronal development 
such as reduced motor axon branching and abnormal neuromuscular junction formation. Although full-
length CPEB4 is nearly exclusively cytoplasmic, the CPEB4 LCD forms nucleolar aggregates and CPEB4 
LCD-expressing animals have altered ribosomal RNA biogenesis, ribosomal protein gene expression, 
and elevated levels of stress response genes such as the actin-bundling protein DRR1, which impedes 
neurite outgrowth. Some of these features share similarities with other LCD-related neurodegenerative 
disease. Most strikingly, DRR1 appears to be a common focus of several neurodevelopmental 
and neurodegenerative disorders. Our study reveals a possible molecular convergence between a 
neurodevelopmental defect and neurodegeneration mediated by LCDs.
Construction of the developing nervous system requires that axons properly synapse on other cells; mostly other 
neurons but sometimes muscles or gland cells. These tasks rely on actin and microtubule cytoskeleton dynamics 
in growth cones, the motile structures at the tips of axons and dendrites1. Undisrupted temporo-spatial gene 
regulation in axons and/or growth cones is critical for proper axonal growth, maintenance, and repair during 
development2. Conversely, developmental abnormalities in synaptic compartments can signal onset of neurolog-
ical disease. For example, spinal muscular atrophy (SMA) is caused by mutation of SMN1 3, which is required for 
survival of motor neurons; reduced SMN1 leads to disturbances in axonal growth and neuromuscular junctions 
(NMJs) that typically precede motor neuron death4,5. Schizophrenia (SZ) is another neurodevelopmental disor-
der associated with axonal abnormalities, which play a role in white matter defects of the disease6. Several axon 
guidance pathway genes such as ROBO2, SLIT3, PLXNA2 are associated with SZ7,8 and one SZ candidate gene, 
Disrupted-In-Schizophrenia 1, participates in neurite outgrowth9. Improper gene regulation in neurites and/or 
growth cones also results in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). In early stage 
ALS, nerve terminals and motor neuron junctions are partially degraded while the spinal cord cell bodies are 
mostly intact10. These observations raise the possibility that the disease might begin with distal axonal abnormali-
ties that progress toward the cell body and cause proximal neuronal cell death, described as a “dying-back hypoth-
esis” for neurodegeneration11. Thus, understanding molecular mechanism(s) of degeneration in distal motor 
axons and NMJs might help elucidate late onset motor neuron pathology. Indeed, mutations in the ALS-causing 
genes SOD1 and TDP-43 inhibit neurite outgrowth in cultured neuronal cells12,13. A newly discovered ALS muta-
tion in Profillin1 also inhibits axon outgrowth14. These observations suggest that neurodevelopmental and neu-
rodegenerative disorders have some features in common, possibly indicating convergent pathogenic pathways.
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The CPEB family of RNA-binding proteins regulates mRNA translation through interactions with specific 
sequences in mRNA 3′ UTRs15,16. All four CPEB proteins are widely expressed in the brain; two of them, CPEB1 
and CPEB3, regulate neuronal synaptic plasticity and learning and memory17–21. CPEB4 is necessary for hip-
pocampal neuronal cell survival, most likely by regulating mRNA processing required for neuroprotection 
against cellular stress22. The expression of CPEB4 is particularly high in the developing brain and spinal cord 
across metazoans, indicating an evolutionarily conserved importance of the protein in the developing nervous 
system. Additionally, CPEB4 is also important in multiple non-neuronal tissues for cancer progression23, patho-
logic angiogenesis24 and terminal erythroid differentiation25.
The CPEB proteins have carboxy terminal (C-term) RNA binding domains that contain two RNA recogni-
tion motifs (RRMs) and two zinc finger (ZF) domains15. They also have amino terminal (N-term) regions with 
little diversity in their amino acid composition, and are hence referred to as low complexity domains (LCDs). In 
contrast to the RNA binding regions, the LCDs are not well-conserved between CPEB family members, although 
they do regulate activity of the proteins26. For example, the LCD of CPEB1 harbors a critical phosphorylation site 
that mediates its translational control function by cytoplasmic polyadenylation27. The LCD of CPEB3 is particu-
larly glutamine-rich and promotes aggregation of amyloid-like fibers in a similar manner to fungal prions28. The 
role of CPEB4 LCD is not known.
Here we provide a link between the LCD of CPEB4 and neuronal dysfunction during development. Expression 
of the CPEB4 LCD results in impaired motor axon extension and neurodevelopment, NMJ formation, and mobil-
ity defects in embryonic and neonatal mice. LCD-mediated toxicity in spinal motor neurons is associated with an 
increased stress response, defective ribosomal RNA (rRNA) metabolism, and impaired actin filament organiza-
tion that perturbs neurite outgrowth. Several of the molecular and physiological readouts caused by CPEB4 LCD 
mimic those seen in other diseases associated with neurodevelopment as well as neurodegeneration. Our study 
suggests a possible molecular convergence between impaired neurodevelopment and neurodegeneration that is 
associated with protein low complexity domains.
Results
Cpeb4 is highly expressed in the nervous system including spinal motor neurons. To investigate 
the functional role of Cpeb4 in the mammalian central nervous system, we analyzed the expression profile of the 
Cpeb4 gene locus during embryonic development by taking advantage of the lacZ insertion in the mutant allele 
of heterozygous gene trap (Cpeb4GT/+) mice obtained from European Mouse Mutant Archive (EMMA ID:04002). 
X-gal staining revealed that Cpeb4 is highly expressed in the nervous system during embryogenesis including 
brain, spinal cord and the attached dorsal root ganglia (DRG) along with other tissues such as heart (Fig. 1A). 
At embryonic day (e) 18.5, Cpeb4 is expressed in the grey matter of spinal cord, which is mainly composed of 
neurons. The diencephalons as well as the hippocampus, part of the midbrain and the hindbrain also show Cpeb4 
expression. At postnatal day (p) 20, expression in the spinal cord and brain persists including CA1 and dentate 
gyrus of hippocampus (Fig. 1A). Immunohistochemical staining of frozen sections from p0 spinal cord and DRG 
with anti-CPEB4 antibody shows the protein to be expressed in these tissues, which are enriched in motor and 
sensory neurons (Fig. 1B; specificity of antibody demonstrated in22,26). CPEB4 is expressed in neurofilament (NF)-
positive neurons (Fig. 1C) in the cell bodies as well as neurites, suggesting involvement of the protein in neuronal 
function. Magnified images from immunocytochemical staining of primary spinal cord neuron cultures show 
that CPEB4 is present in the cell body as well as axons and their growth cones (Fig. 1D). Immunocytochemistry 
of spinal cord primary neuron cultures from transgenic mice expressing GFP only in motor neurons via the Hb9 
promoter29 shows that Hb9::GFP-positive spinal motor neurons express CPEB4 (Fig. 1E). Taken together, our 
data show that CPEB4 is highly expressed in neuronal tissues including brain and spinal cord.
Cpeb4 gene trap mice are neonatal lethal with associated motor dysfunction. To investigate 
the functional role of Cpeb4 in the nervous system, we generated homozygous gene trap (Cpeb4GT/GT) mice by 
crossing heterozygous animals (Cpeb4GT/+). The mutant Cpeb4 allele contains a gene trap cassette with a strong 
splice acceptor (SA) sequence followed by lacZ, neo and a polyadenylation signal (pA)30, which generates trun-
cated transcripts that lack the RRMs and ZFs (starting from exon 5) presumably necessary for protein function 
(Fig. 2A). The mutant transcript is predicted to encode the N-term 375 amino acids of CPEB4 fused to lacZ and 
neo; however, the self-cleaving 2A peptide between CPEB4 exon 1 and lacZ would co-translationally generate 
separate protein products. While the robust expression of full-length CPEB4 protein was detected in the wild type 
spinal cord, exon 1-encoded protein product was readily detected specifically in the Cpeb4GT/GT spinal cord with 
N-term specific antibody for CPEB4 (Fig. 2B) demonstrating that Cpeb4GT/GT mice are not only depleted of the 
full-length but also expressed the mutant form of CPEB4 protein. Little is known about the function of the 375 
amino acids encoded by exon 1, but a disorder tendency plot using the IUPred prediction program (http://iupred.
enzim.hu) indicates this region (highlighted in red in Fig. 2C), as well as a similar region in CPEB2 (green), to be 
highly disordered. TDP-43 and FUS, RNA binding proteins linked to the motor neuron disease ALS, also contain 
disordered domains (green) (Fig. 2C). Disordered regions often serve as hubs for protein-protein interaction 
networks and are involved in biological processes via modulation of the functions of their binding partners31. 
Disordered regions are often encoded by LCDs, which are comprised of relatively few amino acids. Indeed, 57% 
of exon 1 of CPEB4 consists of only six amino acids (Supplemental Fig. S1A,B); in comparison, the frequency of 
these amino acids in the average mouse proteome is ~35%32. Moreover, disordered domains have been implicated 
in a number of human pathologic conditions including Alzheimer’s disease (AD), Parkinson’s disease (PD), and 
ALS31. Therefore, Cpeb4GT/GT mice can provide a unique tool to investigate the functional role of CPEB4 LCD 
in vivo.
We also generated a second Cpeb4 mouse line by deleting exon 2 (Fig. 2A), which would truncate the Cpeb4 
transcript and lead to nonsense-mediated mRNA decay via a premature termination codon (PTC) in exon 3. The 
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exon 2 deletion null mice (Cpeb4ΔE2/ΔE2) were viable (Fig. 2D, top) and overtly normal. Another group recently 
described a similar Cpeb4ΔE2/ΔE2 knockout mouse line that had no discernible phenotype33. They performed 
extensive behavioral tests as well as electrophysiological recordings for synaptic plasticity, which all showed nor-
mal responses for Cpeb4ΔE2/ΔE2 mice33. In contrast to the normal phenotype of Cpeb4ΔE2/ΔE2 mice, we observed 
substantial neonatal lethality of the Cpeb4GT/GT pups. The Cpeb4GT/GT mutant line was previously reported to 
have high mortality within 2 weeks of birth, and the fetal liver had defects in terminal erythroid differentiation25; 
however, the precise cause of the perinatal lethality is unclear and may be attributable to defects in multiple 
tissues. Genotyping of the pups at weaning (p21) confirmed significant reduction of the Cpeb4GT/GT mice at this 
age (Fig. 2D) in agreement with a previous report25. Genotype ratio of the e18.5 embryos is normal, indicating 
postnatal lethality of the mice. Lethality began soon after birth; 50% died within 24 hours and by 21 days only 
~15% survived (Fig. 2E). Strain background of genetically engineered mice is one factor that can influence com-
plicated phenotypes. Even though both Cpeb4GT/GT lines used in this study and Hu et al.25 were initially made in 
C57BL/6NTac background, they were maintained in C57BLl/625, which was also used for Cpeb4ΔE2/ΔE2 mice by 
Tsai et al.33 (Supplemental Fig. S1C) suggesting genetic background may not be the major reason for the different 
lethalities of these mice.
We noticed that Cpeb4GT/GT animals displayed reduced size and weight compared to wild type littermates 
(Fig. 2F). In contrast to Cpeb4+/+ animals, the Cpeb4GT/GT mice contained no milk in their stomachs at p0 
(Fig. 2G). When quantified as full, partially present, or absent, there was a significant reduction in the milk score 
in the Cpeb4GT/GT pups (Fig. 2G). We also observed that these animals had great difficulty in attaching to the 
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Figure 1. Expression pattern of CPEB4. (A) X-gal staining for Cpeb4-lacZ expression in Cpeb4GT/+ embryos 
or dissected spinal cord (top right) and brain (bottom right) from the indicated developmental stages from 
embryonic day (e) 11.5 to postnatal day (p) 20. Dorsal (D) and ventral (V) portion of the spinal cord is indicated 
with an arrow. Cortex (CX) and olfactory bulb (OB) are indicated for the sagittal section of the brain (E18.5). 
CA1 region and dentate gyrus are indicated for the sagittal section of the hippocampus (P20). Scale bars are 
1 mm except for E18.5 spinal cord, which is 100 μ m. (B) Immunohistochemistry of p0 spinal cord (SC) and 
dorsal root ganglia (DRG) using neurofilament (red) and CPEB4 (green) antibodies. (C) Immunocytochemistry 
of CPEB4 protein (green) in primary neuron cultures co-stained with a neuronal (neurofilament) markers 
(red). (D) Confocal microscopy of an axonal growth cone stained for CPEB4 (green) and phalloidin (red, which 
denotes filamentous actin). (E) CPEB4 (red) immunocytochemistry of primary spinal cord motor neuron 
cultures from Hb9::GFP (GFP, green) mice. Scale bars are 100μ m for (B,C,E), 10 μ m for (D).
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Figure 2. Phenotypes of Cpeb4GT/GT mice. (A) Schematic diagram of Cpeb4 WT, Cpeb4 gene trap and 
Cpeb4 exon 2 deletion alleles. White boxes indicate exons of the gene, and the lines indicate introns. For 
coding regions of the Cpeb4 WT allele, functional domains of the CPEB4 protein are indicated with amino 
acid residue numbers on top. NES indicates nuclear export signal; RRM indicates RNA recognition motif; 
ZF indicates a zinc finger domain. The gene trap cassette contains splice acceptor site (SA) site, lacZ, neo 
selection marker gene, and the SV40 polyadenylation sequence (pA). FRT and loxP indicate recombinase 
sites. 2A indicates a self-cleaving protease sequence. PTC indicates premature termination codon introduced 
due to the deletion of exon 2. (B) Western blot analysis of total brain lysate from Cpeb4+/+ vs Cpeb4GT/GT  
mice probed with CPEB4 N-term antibody. Full length and the low complexity domain (LCD; 375 residues 
encoded by exon 1) are indicated. (C) Plots for predicted disorder tendencies of CPEB4 (exon 1 is highlighted 
with red), CPEB2, TDP-43, and FUS; low complexity domains are indicated by green shaded boxes.  
(D) Genotype ratio of the progeny from the Cpeb4ΔE2/+ mating pairs at weaning age (p21) and the progeny 
from the Cpeb4GT/+ mating pairs at e18.5 embryos or weaning age. (E) Survival curve of Cpeb4+/+ (black 
diamonds) and Cpeb4GT/GT (red square) mice after birth (n = 40). (F) Body weight of Cpeb4+/+ (black), 
Cpeb4GT/+ (gray), and Cpeb4GT/GT (red) animals during postnatal development (shown as mean ± SEM).  
(G) P0 Cpeb4+/+ and Cpeb4GT/GT assayed for milk spot (arrow) incidence. (H) Latency of nipple attachment 
in p0 mice (mean ± SEM). In this and all subsequent figures, one asterisk refers to p < 0.05; two asterisks 
refer to p < 0.01; three asterisks refer to p < 0.001.
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mother’s nipple (Fig. 2H and Supplemental Movie S1). Indeed, a nipple attachment test revealed the Cpeb4GT/GT 
pups took three times longer to successfully perform the task relative to Cpeb4+/+ pups (Fig. 2H). A more compre-
hensive analysis of the inability of Cpeb4GT/GT in the behavior test revealed profound uncoordinated movements 
indicative of loss of motor control (Supplemental Movie S1). In addition, we observed occasional gasping of the 
Cpeb4GT/GT pups indicating possible defects in diaphragm function (Supplemental Movie S2). Because Cpeb4 
null mice (Cpeb4ΔE2/ΔE2) exhibited no overt phenotype, we concluded that the lethality as well as motor neuron 
defects in Cpeb4GT/GT mice resulted from a dominant toxic effect of LCD expression rather than depleting full 
length CPEB4 proteins. Cpeb4GT/+ mice were viable and overtly normal (Fig. 2D,F) suggesting mutations from 
both alleles are required for full penetrance of the phenotype.
Motor neuron dysfunction in Cpeb4GT/GT mice. Because of the high expression of Cpeb4 in the spinal 
cord and the movement deficits in Cpeb4GT/GT mice, we suspected that motor neuron development or function 
might be compromised. To analyze defects in motor neurons, we focused on the phrenic nerve, which originates 
from the cervical spinal cord and innervates diaphragm muscles. The axon tracts of whole-mount diaphragm 
were stained with NF antibody, which is previously used to analyze intramuscular motor axon branching in 
several studies34–36. At various stages of development (e14.5 to e18.5), the primary axon branch of the phrenic 
nerve of Cpeb4+/+ animals becomes progressively arborized so that by e18.5, numerous secondary and tertiary 
branches are observed (Fig. 3A, top). In contrast, Cpeb4GT/GT axons are thin and display few arbors at e18.5 
(Fig. 3A, bottom). Tracing of the axon branches of e18.5 phrenic nerves (Fig. 3B) revealed a significant reduction 
in the secondary and tertiary axon branching in Cpeb4GT/GT mice (Fig. 3C), which may be due to defects in the 
initiation/growth of the axonal branches or in the management of such structures, or a combination of both. 
Moreover, co-staining with α -bungarotoxin, a marker for acetylcholine receptors, demonstrated a reduction of 
NMJ formation in these animals (Fig. 3D), which likely explains their movement defects and failure in nipple 
attachment. Quantification of α -bungarotoxin intensity over the diaphragm muscle area showed more than ~50% 
reduction in Cpeb4GT/GT mice (Supplemental Fig. S2A) similar to the loss of axonal terminals, indicating reduced 
innervation and subsequent loss of acetylcholine receptor cluster formation. Neither forelimb nor ophthalmic 
sensory neurons presented axon branching defects (Fig. 3E and Supplemental Fig. S2B), suggesting that motor 
neurons are primarily affected by CPEB4 LCD expression. We expect that the branching defects of the Cpeb4GT/GT 
mice are likely to be attributable to neuronal defects because skeletal muscle tissues did not express CPEB4 pro-
tein shown by western blot analysis (Supplemental Fig. S2C).
To assess whether motor neurons in the spinal cord undergo degeneration, we crossed Cpeb4GT/GT mice with 
Hb9::GFP transgenic mice29. Immunohistochemistry of cervical spinal cords from Hb9::GFP transgenic mice 
showed no discernible difference in the area for GFP-positive motor neurons of the p0 Cpeb4+/+ and Cpeb4GT/GT 
mice, suggesting the defects are specific for axon branching rather than overall cell death (Fig. 3F). In addi-
tion, expression level of a neuronal protein, NeuN, measured by western blot analysis was comparable in the p0 
Cpeb4+/+ and Cpeb4GT/GT spinal cords, which also suggests lack of cell death (Fig. 3G). However, it is possible that 
distal motor axon abnormalities precede the ultimate cell death, which was not captured in the time frame of our 
assay due to the lethality of Cpeb4GT/GT mice at p0.
We also tested the possibility that aged Cpeb4GT/GT mice may exhibit motor neuron degeneration. About 15% 
Cpeb4GT/GT animals survive to adulthood (Fig. 2E) and become indistinguishable from their Cpeb4+/+ littermates. 
Measurement of compound muscle action potential (CMAP), motor unit number estimation (MUNE), motor 
unit (MU) size and electromyography (EMG) score in sciatic nerve of hind limb of 2 year old Cpeb4GT/GT mice did 
not show any statistical difference, indicating absence of detectable motor neuron degeneration (Supplemental 
Fig. S2D). Histological analysis of the skeletal muscles showed no visible pathological changes in the Cpeb4GT/GT 
mice (Supplemental Fig. S2E), in agreement with our electrophysiological analysis, and indicates a lack of motor 
neuron degeneration in adult Cpeb4GT/GT mice.
Low complexity domain-mediated toxicity is associated with nucleolar stress. To investigate 
the molecular lesion(s) caused by CPEB4 LCD, we performed microarray analysis with p0 spinal cord from 
Cpeb4+/+ or Cpeb4GT/GT mice to identify differentially expressed genes (Fig. 4A). Gene ontology (GO) analysis 
of the microarray data revealed that transcripts involved in translation, transport, and protein localization were 
increased whereas mRNAs implicated in cell projection organization and neuron development were decreased 
(Fig. 4B) in the spinal cord of Cpeb4GT/GT mice, which is consistent with the axon branching defects in the 
Cpeb4GT/GT mice (Fig. 3A–D). Of the 8122 RefSeq genes detected above threshold, 1022 (12.58%) were differen-
tially expressed in Cpeb4GT/GT tissue. Among these, 613 (7.55%) were increased and 405 (5.04%) were decreased 
(Fig. 4C). Interestingly, for 65 mRNAs encoding ribosomal proteins, 29% were increased but none were decreased 
in Cpeb4GT/GT spinal cord (Fig. 4C), suggesting CPEB4 LCD may disrupt cellular metabolism related to ribosomal 
function.
To investigate the cellular function of CPEB4 exon 1 LCD, we expressed a GFP tagged version of this 375 
amino acid polypeptide as well as the C-term region (residues 376-712) and the full-length (FL) CPEB4 protein 
in N2a mouse neuroblastoma cells (Fig. 4D–G) or 293T cells (Fig. 4H–I). At steady state, full-length CPEB4 
is predominantly cytoplasmic, even though it shuttles between nucleus and cytoplasm and congregates in the 
nucleus upon cellular stress22. Both GFP-CPEB4 376-712 and GFP-CPEB4 FL were found exclusively in the cyto-
plasm whereas GFP-CPEB4 1-375 resided in nuclei as well as the cytoplasm partially co-localizing with nuclear 
protein FUS (Fig. 4D, see Supplemental Fig. S3 for magnified images). The CPEB4 exon 1 LCD is truncated 
upstream of the nuclear export signal (NES)22 (also see Fig. 2A for location of the NES), which likely accounts 
for its nuclear localization. Subcellular fractionation of the transfected cells showed that GFP-CPEB4 LCD was 
predominantly nuclear (Fig. 4E) agreeing with immunocytochemistry data. Interestingly, nuclear GFP-CPEB4 
1-375 migrates slower than the cytoplasmic proteins (a doublet band in Fig. 4E), which may result from a 
www.nature.com/scientificreports/
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different post-translational modification such as phosphorylation. We also noticed occasional nuclear puncta 
in the CPEB4 LCD-expressing cells (Fig. 4F, white arrowheads) with higher frequency compared to GFP-CPEB4 
C-term region or GFP-CPEB4 FL (Fig. 4G). To investigate subcellular localization of the GFP-positive puncta in 
GFP-CPEB4 1-375 expressing cells, we co-stained the cells with a nucleolar marker, fibrillarin (Fig. 4H). Some of 
the CPEB4-LCD puncta were DAPI-negative and fibrillarin-positive indicating nucleolar localization (Fig. 4H, 
arrowheads). The expression levels of the GFP-tagged CPEB4 proteins (1–375, 376–712 or FL) were comparable 
when microscopically examined (Fig. 4D,F,H) and when they were analyzed using GFP antibody with western 
blot (Fig. 4I). Because nucleoli are sites for ribosome synthesis and assembly, we suspected Cpeb4GT/GT mice may 
have impaired nucleolar function caused by CPEB4 LCD. We analyzed rRNA processing in p0 spinal cord from 
Cpeb4GT/GT mice as readout for nucleolar dysfunction. Quantitative RT-PCR with primers specific for either the 
junctions or mature forms of rRNA revealed that Cpeb4GT/GT had an ~40% increase in the products for 5′ junc-
tions of 5.8S and 28S rRNAs, confirming that rRNA processing was reduced in these mice although mature levels 
of 18S, 5.8S, and 28S were unaffected (Fig. 4J) suggesting a mild impairment of nucleolar function.
Many RNA-binding proteins localize to various nuclear puncta in eukaryotic cells37. Interestingly, the 
repeat-associated non-AUG (RAN) translation products glycine:arginine (GRn) and proline:arginine (PRn) 
dipeptide repeat polymers from the C9orf72 hexanucleotide repeat expansion, which are low complexity by 
Figure 3. Motor neuron phenotype of Cpeb4GT/GT mice. (A) Phrenic nerve motor neuron axon tracts in the e14.5 
to 18.5 Cpeb4+/+ and Cpeb4GT/G diaphragm stained with neurofilament (NF) antibody. (B) Phrenic nerve motor axon 
tract tracing from E14.5 and E18.5 mice. (C) Quantification of the number of branches for e18.5 phrenic nerve from 
Cpeb4+/+ (n = 4) and Cpeb4GT/GT (n = 4) (mean ± SEM). (D) NMJ staining in Cpeb4+/+ and Cpeb4GT/G diaphragm 
with NF antibody (green) and AF594 conjugated α -bungarotoxin (red). (E) Cpeb4+/+ and Cpeb4GT/G E12.5 forelimb 
sensory neurons stained with NF antibody. (F) Immunohistochemistry using GFP antibody for Hb9::GFP positive 
motor neurons in Cpeb4+/+ (7 sections from 2 animals) and Cpeb4GT/GT (9 sections from 3 animals) spinal cords and 
the ratio of area for motor neurons (mean ± SEM). (G) Western blot analysis of Cpeb4+/+ and Cpeb4GT/GT p0 spinal 
cords for neuronal marker (NeuN) and GAPDH. Quantification of the relative NeuN level to GAPDH is shown in 
the histogram (mean ± SEM). Scale bars are 500 μ m for (D) and 100 μ m for (E) and (F).
www.nature.com/scientificreports/
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nature and a major known cause of ALS, are also found in nucleoli where they impede RNA biogenesis and 
increase ribosomal protein mRNA levels, which may be one cause of cell death38. Therefore CPEB4 LCD seems to 
share a pathogenic mechanism with other LC peptide-related diseases. We speculate that RAN polymer induced 
toxicity is not only restricted to neurodegenerative diseases, but may also represent a more general phenome-
non of low complexity peptide-mediated pathogenesis during neurodevelopment including CPEB4 LCD toxicity 
Figure 4. Disordered Cpeb4 exon 1 LCD induces nucleolar stress. (A) Schematic diagram of the analysis 
to identify differentially expressed genes in Cpeb4+/+ and Cpeb4GT/GT p0 spinal cords. Total spinal cord RNAs 
were used for genome-wide microarray analysis. (B) Gene ontology analysis of differentially expressed genes 
shown with − log10 p-value. The transcripts denoted in red are those that increased the most and those in blue 
decreased the most in Cpeb4GT/GT spinal cord. (C) Microarray analysis of differentially expressed genes in p0 
Cpeb4GT/GT versus Cpeb4+/+ spinal cords for all or ribosomal protein mRNAs. (D) N2a cells transfected with 
GFP, GFP-CPEB4 residue 1–375, GFP-CPEB4 376–712, or GFP-CPEB4 full length (FL) were stained with 
GFP and FUS (nuclear protein) antibodies. (E) GFP-CPEB4 1–375 expressing N2a cells were fractionated into 
nuclear and cytoplasmic compartments subjected to western blot analysis probed with the indicated antibodies. 
(F) Magnified images of GFP-CPEB4 1–375 transfected N2a cells stained with GFP antibody. The arrowheads 
denote nuclear/nucleolar puncta. (G) The histogram for percentage of transfected cells with nuclear puncta 
expressing GFP only (n = 68), GFP-CPEB4 1–375 (n = 104), GFP-CPEB4 376–712 (n = 114), and GFP-CPEB4 
FL (n = 96). (H) 293T cells transfected with GFP, GFP-CPEB4 residue 1–375, GFP-CPEB4 376–712, or GFP-
CPEB4 full length (FL) were stained with GFP and fibrillarin (nucleolar marker protein) antibodies. (I) Western 
blot analysis of the lysates from 293T cells transfected with GFP-CPEB4 residue 1–375, GFP-CPEB4 376–712, or 
GFP-CPEB4 full length (FL) with GFP or GAPDH antibodies. (J) rRNA processing in p0 Cpeb4GT/GT (gray bar) 
Cpeb4+/+ (black bar) spinal cord from 3–9 animals analyzed by quantitative RT-PCR (Mean ± SEM). Beneath 
the histogram are the approximate locations of primers for detecting 45S, 18S 5′ junction, 18S, 18S 3′ junction, 
5.8S 5′ junction, 5.8S, 5.8S 3′ junction, 28S 5′ junction, and 28S rRNA. Scale bars are 10 μ m.
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in the Cpeb4GT/GT mice. Furthermore, nucleolar stress presented by nucleolar aggregates and rRNA processing 
defects may be specific examples of such a convergent pathogenic pathway caused by low complexity peptide/
proteins.
An actin binding protein DRR1 is commonly upregulated in neurological disorders. To elucidate 
the molecular mechanism of CPEB4 LCD-mediated toxicity, we further analyzed the differentially expressed 
genes in p0 Cpeb4GT/GT spinal cord. We noticed that several stress response genes such as Drr1 (down-regulated 
in renal cell carcinoma 1, also called family with sequence similarity 107 (Fam107A)), Edn1, Klf9, and Nfkbia39–42 
were significantly increased in Cpeb4GT/GT spinal cord (Fig. 5A), which was independently validated by RT-qPCR 
(Fig. 5B). In contrast, the expression levels of these transcripts were unchanged in the p0 Cpeb4ΔE2/ΔE2 spinal 
cord (Supplemental Fig. S4) suggesting these molecular readouts resulted from a LCD expression rather than 
depleting full length CPEB4 proteins. Among these transcripts, Drr1 was of special interest because it is an actin 
binding protein that modulates actin-dependent neurite outgrowth42, and thus could be directly relevant to the 
Cpeb4GT/GT mouse phenotype. Drr1 mRNA is highly and specifically expressed in various human neuronal tissues 
(Supplemental Fig. S5A). To investigate neuronal expression and subcellular localization of DRR1, we expressed 
FLAG-tagged DRR1 in hippocampal neurons via lentivirus. Ectopically expressed DRR1 is localized not only in 
the cell body but also in neurites and growth cones, co-localizing with filamentous actin denoted by phalloidin 
(Fig. 5C). Drr1 mRNA is regulated by various stresses including treatment with a glucocorticoid agonist, food 
deprivation, and social stress43. Overexpression of Drr1 not only inhibits neurite outgrowth in vitro but also alters 
related social behavior in vivo44.
To test the link between CPEB4 LCD-mediated toxicity and Drr1 regulation, we turned to cultured mouse 
hippocampal neurons for ease of use, which like p0 spinal cord have elevated Drr1 mRNA levels in Cpeb4GT/GT 
compared to Cpeb4+/+ neurons (Fig. 5D). Sholl analysis of neurite branching shows that Cpeb4GT/GT neurons 
have reduced outgrowth compared to Cpeb4+/+ neurons (Fig. 5E). Ectopic expression of Drr1 in Cpeb4+/+ neu-
rons inhibited neurite outgrowth (Fig. 5F)42, while depletion of Drr1 in Cpeb4GT/GT neurons partially rescued 
the reduction in neurite outgrowth (Fig. 5G). These data suggest that the actin binding protein DRR1 is a down-
stream factor in CPEB4 LCD-mediated toxicity of neurons, and may contribute to the neuronal dysfunction of 
the Cpeb4GT/GT mice.
Drr1, together with Nfkbia, is one of 243 commonly altered genes identified using 1,270 post-mortem tissues 
from 13 patient cohorts for four neurodegenerative diseases including ALS, PD, and Huntington’s disease (HD) 
(Fig. 5H and Supplemental Fig. S5B)45. Another gene whose expression is altered in Cpeb4GT/GT spinal cord, Edn1 
is also increased in ALS patients (Fig. 5H)46. Moreover, Drr1 is one of 78 significantly altered genes in cortical 
tissues of 29 bipolar disorder (BPD) and 32 schizophrenia (SZ) patients47. It is also one of 159 altered genes in p5 
spinal cord of a mouse model (Smn− /− ; SMN2) for SMA48 (Fig. 5H). We compared the 243 commonly altered 
genes in neurodegeneration identified by Li, and the 78 commonly altered genes in BPD and SZ identified by 
Shao together with the 159 altered genes in p5 spinal cord of the mouse model for SMA48. Drr1 was the only gene 
alteration shared by the three different studies mentioned above (Fig. 5I) suggesting its importance for neurolog-
ical disease.
DRR1 is an actin bundling protein42 detected in neuronal growth cones (Fig. 5C), which reinforces the notion 
that impedance of cytoskeleton dynamics could have dire consequences for various neuronal defects. These 
observations also support the notion that temporarily distinguishable groups of neurological disease may target 
a common pathological pathway. Therefore, we propose that CPEB4 LCD triggers a stress response that includes 
DRR1 upregulation along with other molecular changes, which subsequently contributes to impairment of neur-
ite outgrowth and NMJ formation via disruption of actin organization (Fig. 6). The fact that elevated Drr1 mRNA 
occurs in other neurological diseases suggests a potentially broad role of DRR1 and actin filament organization 
pathway in neuronal pathology for both development and degeneration.
Discussion
We characterized a mouse model (Cpeb4GT/GT) that expresses truncated CPEB4 protein but no full-length protein. 
Because Cpeb4 null mice (Cpeb4ΔE2/ΔE2) exhibit no overt phenotype33 (Fig. 2D), we speculate that key phenotypes 
of the Cpeb4GT/GT animals presented in this study are exclusively due to expression of the LCD. The mobility defi-
cits, impaired motor axon branching, abnormal NMJ formation, and altered molecular readouts of the Cpeb4GT/GT 
embryonic and neonatal mice described in this study suggest a potential relationship between LC protein toxicity 
and neurodevelopmental disease. Accumulating evidence has clearly linked LCD-containing proteins to neuro-
degeneration through pathogenic mechanisms, in part, involving accelerated protein aggregation. This phenome-
non is perhaps best exemplified by the polyglutamine oligomers seen in CAG repeat expansion diseases including 
HD, spinal bulbar muscular atrophy (SBMA), and spinocerebellar ataxia (SCA). The expanded polyglutamine 
peptides can assemble into large self-associated oligomers whose possible toxicity is correlated with disease. RAN 
translation products generated from microsatellite repeat expansions in several neurological diseases may be 
other illustrations of LCD toxicity. CAG repeats in SCA8, CTG repeats in myotonic dystrophy (DM) type 1, and 
CGG repeats in Fragile X tremor ataxia syndrome (FXTAS) all produce homopolymeric peptides that accumulate 
in human patient tissues49. ALS-causing GGGGCC repeats produce multiple poly-dipeptides, which produce 
toxic effects in cell cultures and animals38,50,51. In these and other cases, the precise cause of the toxicity remains 
elusive.
Interestingly, aberrant cleavage of protein fragments harboring LC region is often associated with several 
neurological diseases. For example, SCA3 is caused by abnormal expansion of the polyglutamine in the C-term 
region of the protein, and the cleavage of the C-term fragment by caspases has been suggested to be essential for 
pathology of the disease52. Similarly in HD, proteolytically cleaved Huntingtin fragments containing expanded 
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Figure 5. Actin binding protein DRR1 level is elevated in Cpeb4GT/GT (A) Microarray analysis of differentially 
expressed genes in p0 Cpeb4GT/GT versus Cpeb4+/+ spinal cords for all detected mRNAs. All 8122 detected RNAs 
were plotted as fold change (ordinate) in Cpeb4GT/GT versus Cpeb4+/+ compared to − log10 p-value (abscissa). 
Transcripts for Drr1, Edn1, Klf9, and Nfkbia are highlighted in red. (B) Quantitative RT-PCR of Drr1, Edn1, 
Klf9, and Nfkbia RNAs normalized to Ppia mRNA from Cpeb4+/+ and Cpeb4GT/GT spinal cord (mean ± SEM). 
(C) Mouse hippocampal neurons expressing ectopic FLAG tagged DRR1 are stained with FLAG antibody 
(green) or phalloidin (red, which denotes filamentous actin). Insets (bottom) are magnified images of a growth 
cone. Image on the left side is a black/white image of the same neuron to indicate cell body, neurite and growth 
cone of the neuron. Scale bar is 20 μ m. (D) RT-PCR for Drr1 expression in DIV 4-7 hippocampal neurons from 
Cpeb4+/+ and Cpeb4GT/GT mice, or neurons expressing ectopic Drr1, a scrambled shRNA, or an shRNA directed 
against Drr1. (E) Sholl analysis to determine neurite branching in hippocampal neurons from Cpeb4+/+ (n = 76) 
vs Cpeb4GT/GT mice (n = 111) (mean ± SEM). (F) Sholl analysis of WT (n = 15) or neurons expressing ectopic 
Drr1 (n = 12). (G) Sholl analysis of neurons expressing scrambled (n = 43) or Drr1 shRNAs (n = 36). (H) Heat 
map for expression level of Drr1, Nfkbia and Edn mRNAs in Cpeb4GT/GT spinal cord and various neurological 
disorders. Heat map colors correspond to log2 fold changes compared to WT animals or control groups and 
original research article is indicated for each analysis. (I) Venn diagram to indicate commonality of regulated 
transcripts among three studies. 243 commonly altered genes in neurodegeneration by Li (2014) (ALS, HD, 
PD), 78 commonly altered genes in SZ and BPD by Shao47, and 159 differentially expressed genes in p5 spinal 
cord of Smn− /− ; SMN2 mouse (fold change > 1.5) by Murray48 were compared for overlapping genes.
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polyglutamine repeats may be required to initiate toxicity related to disease neuropathology53. In addition, in 
the case of ALS, aberrant cleavage of TDP-43 C-term region containing disordered LCD contributes to enhance 
aggregation and cellular toxicity54,55. These and other observations suggest aberrant protein truncation and result-
ing expression of LCD peptides/proteins may be a general pathogenic mechanism for neurological disease.
The aberrant expression of CPEB4 LCD induces some forms of cellular stress, which is manifest by increased 
levels of a specific set of stress response genes and formation of nucleolar puncta and altered rRNA biogenesis, 
some of which are also seen in diseases such as SMA and ALS45,48,51,56. We have no evidence of neurodegeneration 
in fetal or adult Cpeb4GT/GT mice (indeed, our data indicate lack of cell death), but we find that axon development 
in the embryo is impaired, which likely contributes to the high mortality rate in the few weeks after birth. Thus, 
we surmise that a recapitulation of CPEB4 LCD gain-of function toxicity in humans would be most likely to result 
in fetal or infant mortality.
One important finding of our study is that the actin-bundling protein DRR1 may be a target of neuron dys-
function. Drr1 is one of a few mRNAs that is up-regulated in the spinal cords of Cpeb4GT/GT mice and is likely 
to be at least partly responsible for impaired axogenesis (Fig. 5E–G). Originally found to be down-regulated 
in renal carcinoma, DRR1 is also thought to mediate malignant glioma invasion by reorganizing the actin 
Figure 6. Proposed model for a convergent pathway of LCD-mediated toxicity. In normal neurons, neurites 
are well arborized and synapse to healthy muscles to form NMJ. In CPEB4 LCD (green) expressing developing 
neurons, CPEB4 LCD induces cellular stress as well as DRR1 (red circle) up-regulation, which inhibits F-actin 
(small orange circles) polymerization for neurite outgrowth in axons and growth cones (black rectangle). The 
consequences are defects in axon branching and NMJ formation (axon is not extended to muscles). In LCD-
related neurodegeneration disorders such as ALS, LCD aggregates are generally localized in the cytoplasm 
(and in nucleoli in Kwon et al.38), which induces stress, DRR1 expression, and eventually neuronal cell death 
(indicated by fragmented axonal compartments and shrunken muscles).
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cytoskeleton57,58. More importantly, DRR1 expression is specific to neuronal tissues (Supplemental Fig. S5A) and 
DRR1 is localized to growth cones of cultured hippocampal neurons (Fig. 5C), which are the mobile tips of 
developing neurites where the DRR1 protein co-localizes with actin filaments and promotes their stabilization42. 
When ectopically expressed, DRR1 partially abrogates actin-dependent neurite outgrowth, and viral-mediated 
ectopic expression in mouse brain CA3 region of the hippocampus alters cognitive performance as well as social 
interactions42,44. Additionally, Drr1 is highly expressed in human outer radial glia, the neural stem cells of the 
neocortex, during cortical development, suggesting its importance in the coordination of neurodevelopment59. 
Taken together, these observations suggest an underappreciated role of DRR1 in neuron development, mainte-
nance and maybe repair through regulating actin dynamics. One model, therefore, posits involvement of DRR1 
up-regulation in LCD-mediated neurodegeneration as well as in impaired axon development (Fig. 6). While 
axons grow and synapse to healthy muscles in normal neurons, in case of Cpeb4GT/GT mice, CPEB4 LCD protein 
induce cellular stress that increases DRR1 in axons and growth cones that impedes polymerization of F-actin, 
which inhibits neurite outgrowth and promotes axon thinning, defects in branching, and abnormal NMJ forma-
tion. CPEB4 LCD proteins localize not only diffusely to nucleoplasm and cytoplasm, but also to nucleolar puncta. 
The precise degree of pathogenic contribution from the nucleolar CPEB4 LCD aggregates is unclear even though 
perturbation of genes related to ribosome function (i.e., ribosomal protein encoding genes) was observed. In 
LCD-related neurodegeneration such as ALS, LCD aggregates are generally localized in cytoplasm and correlated 
with cellular stress (and eventual cell death) as well as increased DRR1. We propose that DRR1 may be an impor-
tant contributing factor in degeneration, and thus could be a focal molecule for convergent pathways for various 
LCD-related neurological disorders.
In summary, we report that the CPEB4 LCD impairs neuron development that results in reduced motor axon 
branching and diminished NMJ formation in embryos and uncoordinated movement in neonatal mice. At least 
one important molecular lesion is the elevated expression of DRR1, whose actin bundling activity likely impedes 
neurite outgrowth. Heightened DRR1 levels appear to be a general feature of neuron pathology, and thus may be 
a common link among various neurological diseases. We propose molecular readouts of this mouse model may 
reveal important pathways that are widely involved in neurodevelopmental and neurodegenerative disease.
Methods
Mice. Animal protocols were approved for use by the University of Massachusetts Medical School Institutional 
Animal Care and Use Committee (IACUC). All experimental procedures were performed in accordance with the 
approved protocols. Heterozygous Cpeb4 gene trap (Cpeb4tm1a(EUCOMM)Wtsi, EMMA ID:04002, Cpeb4GT/+) mice 
were obtained from European conditional mouse mutagenesis program. For motor neuron identification in spi-
nal cord, Cpeb4GT/+ was bred to Hb9::GFP animals obtained from the Jackson Laboratory (B6.Cg-Tg(Hlxb9-
GFP)1Tmj/J, stock number 005029). To generate Cpeb4ΔE2/ΔE2 null mice, Cpeb4GT/+ mice were bred to C57Bl6/J 
congenic ROSA26::FlpE knock-in mice and protamine Cre transgenic mice that were obtained from Dr. Gregory 
Pazour (University of Massachusetts Medical School).
Genotyping. To obtain genomic DNA, tails snips were lysed in protease buffer (50 mM KCl, 10 mM Tris-HCl 
pH 8.3, 2.5 mM MgCl2, 0.45% NP-40, 0.45% Tween-20, 150 ng/μ l proteinase K) at 60 °C for 45 minutes. PCR was 
performed with 35 cycles of 30″ at 95 °C, 30″ at 60 °C, and 30″ at 72 °C. GFP, FlpE, and Cre genotyping was done 
following the Jackson Lab protocol.
Mouse behavior analysis. Body weight was measured with 2–3 animals at P0, 5–9 animals at P4, and 6–10 
animals at P13. Gastric milk spots in p0 newborn Cpeb4+/+ (n = 13) or Cpeb4GT/GT (n = 15) mice were observed 
mid-morning and categorized in three groups: absent, partially full, and full. For the nipple attachment test, the 
mother was anesthetized and laid with belly up and p0 Cpeb4+/+ (n = 9) or Cpeb4GT/GT (n = 6) pups placed on 
the nipple. Each pup received help until the moment it was successfully attached, and time for attachment was 
recorded. 300 seconds was the maximum duration of the test.
RNA extraction and RT-PCR. Trizol-extracted total RNA was used for reverse transcription (1–5 ug of 
RNA) with Super Script III (Invitrogen). PCR with cDNA was performed routinely using 2x GoTaq (Promega).
Whole mount staining. For X-gal staining, whole embryos or dissected tissues were fixed in 0.2% glutaral-
dehyde, 2% formalin, 5 mM EGTA, and 2 mM MgCl2 in 0.1 M phosphate buffer and stained with 1 mg/ml x-gal, 
5 mM potassium ferricyanide, and 5 mM potassium ferrocyanide. After washing with PBS, they were photo-
graphed and stored in 80% ethanol at 4 °C. Cpeb4GT/+ tissues were always stained together with Cpeb4+/+ litter-
mates to serve as controls. Whole-mount NF staining for mouse diaphragm was performed as described60 using 
2H3 antibody (Developmental studies hybridoma bank), and right ventral region of the diaphragm was photo-
graphed. The diaphragm was also co-stained with Alexa Fluor 594 conjugated α -bungarotoxin (Life science) to 
visualize NMJs. Axon tract tracing was performed using ImageJ plugins, MosaicJ and NeuronJ.
Immunostaining for spinal motor neurons. Freshly harvested mouse spinals cords were fixed with 4% 
paraformaldehyde overnight, immersed in 30% sucrose/PBS, and embedded with OCT. 20 μ m thick serial sec-
tions were prepared for every 200 μ m. Cryosections were blocked with blocking solution (3% BSA, 5% goat serum 
in PBS with 0.1% Triton X-100). Sections were then incubated with anti-GFP antibody (Abcam) followed by 
FITC-conjugated secondary antibody. Binary images of GFP positive area were made to calculate area for motor 
neurons in each section.
Microarray gene expression analysis. Spinal cords from several p0 Cpeb4+/+ or Cpeb4GT/GT were pooled 
to reduce individual variability and subjected to Illumina MouseRef-8 BeadChip microarray assays containing 
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approximately 18,000 RefSeq transcripts. Further analysis on duplicates of samples was performed by using 
Agilent GeneSpring GX software. 8122 RefSeq genes were detected above threshold (expression level > 100), 1022 
(12.58%) of which were differentially expressed in Cpeb4GT/GT tissue (paired t-test, p < 0.1). For gene ontology 
analysis, DAVID functional annotation tool (http://david.abcc.ncifcrf.gov/) was used. A complete list of differen-
tially expressed genes is in Supplemental Table 1.
Quantitative real-time PCR. Real time PCR was performed with an ABI 7300 instrument with Maxima 
SYBR green with ROX (Fermentas). For quantification of gene expression, the Δ Δ Ct method was used normal-
izing to Ppia.
Recombinant protein and antibody purification. A CPEB4 N-term 188 residue fragment was cloned 
into pET28a to generate His-tagged recombinant protein, which was purified on Ni-NTA resin (Thermo 
Scientifics) and used for CPEB4 antibody affinity purification.
Lentiviral vector cloning. FLAG tagged Drr1 was amplified and ligated into pFUGW lentiviral expression 
vector using BamHI and EcoRI sites. For knockdown of Drr1, gene specific oligonucleotides were annealed and 
inserted into the pll3.7-Syn lentiviral shRNA vector.
Cell culture, transfection, and lentivirus transduction. The culture and maintenance of primary spi-
nal cord61 and hippocampal neurons were performed as described62 in neurobasal medium containing 2% B27 
and 1% Glutamax. HEK293T and N2a cells were routinely cultured using 10% FBS and 1% antibiotic, antimy-
cotic in DMEM (Gibco). Triple transfection for virus production was performed as follows: for 80% conflu-
ent HEK293T cells in 10 cm dish, 5 μ g lentiviral vector, 2.5 μ g pMD2.G, and 4 μ g psPAX2 was used with 20 ul 
Lipofectamine 2000. After 72 hours, the supernatant was collected, filtered and used for transduction.
Subcellular fractionation and localization. Subcellular fractionation was done as previously described63. 
Fractionated proteins were subjected to western blot analysis using anti-lamin A/C (Cell Signaling), anti-H3 
(Abcam), and anti-alpha tubulin (Sigma).
Immunocytochemistry. Cells were grown on coverslips, fixed with 4% paraformaldehyde (PFA), blocked 
with blocking solution, immunostained with GFP (Abcam) or FUS (Bethyl lab) antibody. The Z stack maximum 
projection images were obtained using ImageJ software. For detection of nuclear puncta, all stacks were individu-
ally examined. All microscope settings were kept constant for all images taken in one experiment.
Sholl analysis. Hippocampal neurons were grown on poly-L-lysine (Sigma) coated coverslips for 4–7 days, 
fixed in 4% PFA, and stained with anti-alpha tubulin (Sigma) to visualize neurites. Sholl analysis was performed 
as described64.
Statistics. In all panels, one asterisk indicates p < 0.05, two asterisks indicate p < 0.01, and three asterisks 
indicate p < 0.001 (Student’s t test).
Analysis of NCBI Gene Expression Omnibus (GEO) data sets. The concept of using publically avail-
able gene expression microarray studies for neurodegenerative diseases and the method for data collection was 
adapted from a published study45. The processed gene expression data sets for seven different gene expression 
microarrays were downloaded and analyzed using GEO2R available at http://www.ncbi.nlm.nih.gov/geo/geo2r. 
The log2 fold change values for Drr1, Nfkbia, and Edn1 were obtained to generate a heat map for visualization of 
the expression level changes in the neurodegenerative diseases. Data sets for Smn-/-;SMN2 mouse (fold change > 
1.5 for p5 spinal cord) and schizophrenia/bipolar patients were obtained from the literature47,48.
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